The invention relates to a novel pharmaceutical composition comprising an effective
amount of bio-active fraction from cow urine distillate as a bioavailability facilitator
and pharmaceutically acceptable additives selected from anticancer compounds, antibiotics,
drugs, therapeutic and nutraceutic agents, ions and similar molecules which are
targeted to the living systems.
